FDA raises Phenergan warning

The New York Times has decided to require makers of an intravenous anti-nausea drug to put a strict warning on its label. The drug, Phenergan (also known as promethazine), can cause gangrene and serious tissue damage when injected into an artery. The FDA’s ruling resulted after reports of severe personal injuries from arterial injections.

To read more about the FDA Phenergan warning.

Lawyer Monthly - Legal Awards Winner
The National Trial Lawyers
Elder Care Matters Alliance
American Association for Justice
Fellow Litigation Counsel of America
Super Lawyers
Contact Information